JNJ Stock Recent News

Dividend stock investing offers a reliable path to passive income and long-term wealth creation, making it a cornerstone for many portfolios. By owning shares in companies that pay regular dividends, investors gain consistent cash flow, often from stable, high-quality firms like Coca-Cola (NYSE:KO) or Johnson & Johnson (NYSE:JNJ). Dividends provide a hedge against market volatility, as payouts persist even during downturns, and reinvesting them can compound returns significantly over time. Moreover, dividend-paying stocks historically outperform non-dividend peers, with lower volatility. 24/7 Wall St. Insights: Dividend stock investing has proven a reliable path for investors to gather immense wealth over time. Dividend ETFs bolster those results by investing in hundreds of dividend-paying stocks, offering instant diversification and minimizing single-stock risk. Sit back and let dividends do the heavy lifting for a simple, steady path to serious wealth creation over time. Grab a f

Johnson & Johnson said on Friday its experimental psoriasis drug met the main goal in a late-stage study on patients 12 years and older.

66% of patients with scalp psoriasis and 77% with genital psoriasis treated with investigational icotrokinra achieved site-specific clear or almost clear skin at Week 16 Icotrokinra continues to demonstrate a standout combination of significant skin clearance (IGA 0/1) and a favorable safety profile in a once daily pill SPRING HOUSE, Pa. , May 9, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new data from the Phase 3 ICONIC-TOTALa study investigating icotrokinra (JNJ-2113), the first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor.

Investors love dividend stocks, especially high-yield ones, because they offer significant income streams and have substantial total return potential.

Jared Holz, Mizuho, joins 'Fast Money' to talk headwinds to the pharma sector.

NEW ORLEANS--(BUSINESS WIRE)--A jury has awarded $3 million to the family of Jeanine Henderson, a 72-year-old mother from New Orleans who died from mesothelioma, a rare and incurable cancer caused by asbestos exposure, after a lifetime of using Johnson & Johnson's Baby Powder. After a two-month trial, attorneys from Dean Omar Branham Shirley successfully proved that Ms. Henderson's daily use of the talc-based powder was directly linked to her illness. The legal team also presented clear evi.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson today announced the expansion of its efforts to champion the nursing workforce and improve access to quality care for communities around the world. These efforts are part of J&J CareCommunity, a new social impact platform that focuses the resources and expertise of J&J and J&J Foundation to support nurses at every step of their career journey and strengthen health systems worldwide. The expansion aims to help address the gl.

Stocks have rebounded sharply off their early-April lows, but macro risks persist. Dividend stocks have largely outperformed so far this year. We profile a pair of blue chips that recently announced dividend hikes, which has turned out to be a broader Q2 theme.

There's no such thing as a safe stock, but these low-volatility names stand up relatively well in shaky markets.

Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.